Tepilta® Versus Oxetacaine, Antacids and Placebo
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01336530 |
|
Recruitment Status :
Terminated
(The study stopped prematurely due to and administrative reasons, not based on grounds of safety.)
First Posted : April 18, 2011
Last Update Posted : May 19, 2017
|
Sponsor:
MEDA Pharma GmbH & Co. KG
Collaborators:
Trium Analysis Online GmbH
ICON plc
Clinipace Worldwide
Information provided by (Responsible Party):
MEDA Pharma GmbH & Co. KG
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | January 2017 |
| Actual Study Completion Date : | January 2017 |